Multi-aspect approach to the optimization of pharmacotherapy of patients with arterial hypertension of high and very high risk

Personalization of pharmacotherapy of cardiovascular diseases is one of the urgent problems of cardiology antihypertensive treatment with the inclusion of amlodipine and lisinopril or ramipril in patients with arterial hypertension, having a slow and very slow oxidative metabolism phenotype, is characterized by the development of a more pronounced hypotensive effect in this group of patient